awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35094669-C2951703-57D3-4E90-BC1E-C5F8DF4DB207
Q35094669-C2951703-57D3-4E90-BC1E-C5F8DF4DB207
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35094669-C2951703-57D3-4E90-BC1E-C5F8DF4DB207
Novel therapies for renal cell carcinoma--an update.
P2860
Q35094669-C2951703-57D3-4E90-BC1E-C5F8DF4DB207
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35094669-C2951703-57D3-4E90-BC1E-C5F8DF4DB207
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4e4e6faa9f84adbae9c67931eac73808073772c
P2860
Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma.